Lan blood group system

From WikiMD's WELLNESSPEDIA

The Lan blood group system is one of the many blood group systems in humans. It is characterized by the presence or absence of the Lan antigen on the surface of red blood cells. The Lan antigen is a high-prevalence antigen, meaning it is present in the majority of the population.

Diagram of autosomal recessive inheritance.

Discovery[edit]

The Lan blood group system was first identified in the late 20th century. It was named after the first patient in whom the Lan-negative phenotype was discovered. The Lan antigen is encoded by the ABCB6 gene, which is located on chromosome 2.

Genetics[edit]

The Lan blood group system is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the recessive allele, one from each parent, to express the Lan-negative phenotype. Individuals with one copy of the recessive allele and one copy of the dominant allele will express the Lan-positive phenotype.

Clinical Significance[edit]

The Lan blood group system is clinically significant in blood transfusion and organ transplantation. Individuals who are Lan-negative may develop alloantibodies against the Lan antigen if exposed to Lan-positive blood. This can lead to hemolytic transfusion reactions if Lan-negative individuals receive Lan-positive blood.

Prevalence[edit]

The Lan-negative phenotype is extremely rare, occurring in less than 1% of the population worldwide. It is more commonly found in certain ethnic groups, such as the Romani people.

Testing[edit]

Testing for the Lan blood group is typically performed using serological methods. Molecular testing can also be used to identify the presence or absence of the ABCB6 gene variant associated with the Lan-negative phenotype.

Related Pages[edit]

Template:Blood groups

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.